Perry Halushka to Cardiovascular Diseases
This is a "connection" page, showing publications Perry Halushka has written about Cardiovascular Diseases.
Connection Strength
0.748
-
Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers. Annu Rev Pathol. 2019 01 24; 14:211-238.
Score: 0.367
-
Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation. 2002 Apr 09; 105(14):1620-2.
Score: 0.117
-
The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis. 2016 11; 254:271-281.
Score: 0.079
-
The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease. Trans Am Clin Climatol Assoc. 1994; 105:95-103.
Score: 0.066
-
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease. Ration Drug Ther. 1985 Jul; 19(7):1-7.
Score: 0.036
-
Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM. 2005 May; 98(5):349-56.
Score: 0.036
-
Thromboxane A2 receptors. J Lipid Mediat Cell Signal. 1995 Oct; 12(2-3):361-78.
Score: 0.019
-
Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 01; 91(11):2742-7.
Score: 0.018
-
Thromboxane A2 in health and disease. Fed Proc. 1987 Jan; 46(1):131-2.
Score: 0.010